Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment [Yahoo! Finance]
Sana Biotechnology (SANA) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey [Seeking Alpha]
Sana Biotechnology (SANA) had its "outperform" rating reaffirmed by Wedbush.
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451